Embody vs TMates: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

TMates beats Embody overall, scoring 7.8/10 vs 7.3/10. TMates is more affordable at $158/mo vs $299/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose TMates for users who want flexible pricing across compounded glp-1s (me.

A side-by-side comparison of Embody and TMates covering pricing, scores, medication types, insurance, and more to help you decide.

Embody

#38 of 48
7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody
Higher Rated

TMates

#16 of 48
7.8/10

Telemedicine platform offering two distinct archetypes: compounded semaglutide and tirzepatide with medication included (commitment pricing $158-$249/mo), and a clinical-service-only path to brand-name Wegovy/Zepbound at $99/mo where the prescription is sent to the patient's pharmacy. Phentermine also available. 2026 expansion added brand-name FDA-approved options.

Visit TMates
FeatureEmbodyTMates
Our Score7.3/107.8/10
Starting Price$299/mo$158/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoYes
Best ForPeople who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser planUsers who want flexible pricing across compounded GLP-1s (medication included, $158-$249/mo with commitment discounts) and a cheap clinical-service-only path to brand Wegovy or Zepbound ($99/mo, patient fills at own pharmacy)
Ranking#38#16

Pros & Cons Compared

Embody

Pros

  • +Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
  • +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
  • +'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
  • +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
  • +Replies to every negative Trustpilot review, usually within 24 hours.

Cons

  • Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
  • Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
  • Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
  • No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
  • Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
  • If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.

TMates

Pros

  • +Steep multi-month commitment discounts on compounded sema — $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
  • +Clinical-service-only path to brand Wegovy and Zepbound at $99/mo — prescription goes to patient's pharmacy (you fill separately using insurance or cash)
  • +Same price at all dose levels for compounded — no cost escalation as you titrate up
  • +Phentermine available at $149/mo for patients who benefit from a different appetite-suppressant approach

Cons

  • Brand Wegovy/Zepbound $99/mo is CLINICAL SERVICE ONLY — medication cost is separate (paid at your pharmacy, which can be $1,000+/mo cash without insurance)
  • Best compounded pricing requires 6-12 month prepayment (upfront $1,050-$1,900)
  • 90-second assessment quiz suggests convenience over clinical thoroughness compared to competitors with full medical intakes
  • Not affiliated with Novo Nordisk (Wegovy) or Eli Lilly (Zepbound) — TMates prescribes but does not dispense brand-name

Our Verdict

TMates edges out Embody with a score of 7.8/10 vs 7.3/10. If budget is your priority, TMates starts at $158/mo compared to Embody's $299/mo. TMates accepts insurance, which can significantly reduce your out-of-pocket costs. TMates offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose TMates if you want: users who want flexible pricing across compounded glp-1s (medication included, $158-$249/mo with commitment discounts) and a cheap clinical-service-only path to brand wegovy or zepbound ($99/mo, patient fills at own pharmacy).

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Embody nor TMates feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Embody

Starting at $299/mo

Visit Embody

Try TMates

Starting at $158/mo

Visit TMates

Related comparisons

Other matchups readers comparing Embody or TMates tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.